New
ScienceMore in Science→
Study links GLP-1 drugs to a small rise in rare vision-loss risk
Key Takeaways
- A Rutgers-led study associated GLP-1 use with a modest increase in ischemic optic neuropathy.
- The condition was rare but can cause sudden and potentially permanent vision loss.
- The analysis involved US adults aged 18 to 65 with Type 2 diabetes who had recently started treatment.
DE
DT Editorial Team··via sciencedaily.com